The rising prevalence in GLP-1 drugs for diabetes has sparked a debate about formats: patches versus pills . Typically, GLP-1 therapies were exclusively available in oral form, but the development of skin applications offers a alternative option . Patches might benefit individuals facing issues with tablets , those wanting to reduce first-pass l… Read More